Completed PHASE2 INTERVENTIONAL 2-arm NCT00218335

A Network & Dyad HIV Prevention Intervention for IDU's - 1

A Network & Dyad HIV Prevention Intervention for IDU's

Sponsor: Johns Hopkins Bloomberg School of Public Health

Interventions Control Condition Intervention Condition

Updated 7 times since 2017 Last updated: Mar 7, 2013 Started: Jun 30, 2003 Primary completion: May 31, 2008 Completion: May 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on HIV and Hepatitis, this trial is completed. The trial is conducted by Johns Hopkins Bloomberg School of Public Health and has accumulated 7 data snapshots since 2003. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE2
Dec 2022 — Jan 2023 [monthly]

Completed PHASE2
Jan 2021 — Dec 2022 [monthly]

Completed PHASE2

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jun 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Johns Hopkins Bloomberg School of Public Health
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Data source: Johns Hopkins Bloomberg School of Public Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States